SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001214659-21-008188
Filing Date
2021-08-05
Accepted
2021-08-05 17:15:55
Documents
3
Group Members
ATHOS KGDR. MATTHIAS HALLWEGERFCP BIOTECH HOLDING GMBHFCPB AFFI GMBHFIRST CAPITAL PARTNER GMBHHMW EMISSIONSHAUS AGHMW KOMPLEMENTAR GMBHHMW VERWALTUNGS GMBHMICHAEL MOTSCHMANNMIG ASSET TRUST GMBHMIG GMBH & CO. FONDS 11 KG I.L.MIG GMBH & CO. FONDS 12 GESCHLO

Document Format Files

Seq Description Document Type Size
1 r83210sc13g.htm SC 13G 319440
2 EXHIBIT 1 ex1.htm EX-1 26345
3 EXHIBIT 24.1 ex24_1.htm EX-24.1 4972
  Complete submission text file 0001214659-21-008188.txt   353182
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89853 | Film No.: 211149493
SIC: 2834 Pharmaceutical Preparations

Mailing Address KARL FARKAS GASSE 22 VIENNA C4 1030
Business Address KARL FARKAS GASSE 22 VIENNA C4 1030 0043 1 798 15 75 300
AFFiRiS AG (Filed by) CIK: 0001876820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G